Grupo Herdez, S.A.B. de C.V. (BMV:HERDEZ)
Mexico · Delayed Price · Currency is MXN 53.47
-0.46 (-0.85%)
Aug 11, 2025, 1:54 PM CST
Ligand Pharmaceuticals Income Statement
Financials in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 38,662 | 37,425 | 36,213 | 31,646 | 26,153 | 24,036 | Upgrade | |
Revenue Growth (YoY) | 4.46% | 3.35% | 14.43% | 21.00% | 8.81% | 7.21% | Upgrade |
Cost of Revenue | 23,157 | 22,464 | 22,135 | 20,440 | 16,501 | 15,048 | Upgrade |
Gross Profit | 15,505 | 14,961 | 14,078 | 11,206 | 9,652 | 8,988 | Upgrade |
Selling, General & Admin | 10,174 | 9,740 | 9,096 | 7,494 | 6,567 | 6,141 | Upgrade |
Other Operating Expenses | -196 | -117.54 | -69.23 | -68.39 | 58.52 | -31.39 | Upgrade |
Operating Expenses | 9,978 | 9,622 | 9,027 | 7,426 | 6,626 | 6,110 | Upgrade |
Operating Income | 5,527 | 5,339 | 5,051 | 3,780 | 3,026 | 2,878 | Upgrade |
Interest Expense | -1,081 | -1,082 | -1,074 | -1,050 | -848.49 | -906.9 | Upgrade |
Interest & Investment Income | 311.11 | 341.14 | 338.25 | 268.89 | 133.01 | 342.81 | Upgrade |
Earnings From Equity Investments | 541.81 | 408.98 | 771.9 | 466.07 | 803.1 | 756.98 | Upgrade |
Currency Exchange Gain (Loss) | -979.84 | -1,095 | -294.83 | 51.6 | 12.09 | 62.64 | Upgrade |
Other Non Operating Income (Expenses) | 1,033 | 1,033 | 302.75 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 5,353 | 4,944 | 5,095 | 3,516 | 3,126 | 3,134 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -2.75 | Upgrade |
Gain (Loss) on Sale of Assets | -16.74 | -18.55 | -22.79 | 3.01 | -4.38 | 251.91 | Upgrade |
Asset Writedown | -37.65 | -56.25 | -46.34 | - | - | - | Upgrade |
Other Unusual Items | -4.57 | - | 31.39 | - | -39.94 | -42.26 | Upgrade |
Pretax Income | 5,303 | 4,885 | 5,065 | 3,530 | 3,106 | 3,342 | Upgrade |
Income Tax Expense | 1,692 | 1,537 | 1,740 | 1,265 | 1,028 | 973.66 | Upgrade |
Earnings From Continuing Operations | 3,611 | 3,348 | 3,326 | 2,266 | 2,078 | 2,368 | Upgrade |
Minority Interest in Earnings | -2,188 | -1,988 | -2,005 | -1,489 | -1,353 | -1,540 | Upgrade |
Net Income | 1,423 | 1,360 | 1,320 | 776.62 | 725.73 | 827.96 | Upgrade |
Net Income to Common | 1,423 | 1,360 | 1,320 | 776.62 | 725.73 | 827.96 | Upgrade |
Net Income Growth | -0.42% | 2.99% | 70.02% | 7.01% | -12.35% | -18.39% | Upgrade |
Shares Outstanding (Basic) | 321 | 324 | 332 | 341 | 359 | 382 | Upgrade |
Shares Outstanding (Diluted) | 321 | 324 | 332 | 341 | 359 | 382 | Upgrade |
Shares Change (YoY) | -2.30% | -2.22% | -2.73% | -4.91% | -6.08% | -6.82% | Upgrade |
EPS (Basic) | 4.43 | 4.19 | 3.98 | 2.28 | 2.02 | 2.17 | Upgrade |
EPS (Diluted) | 4.42 | 4.19 | 3.98 | 2.28 | 2.02 | 2.17 | Upgrade |
EPS Growth | 1.62% | 5.33% | 74.80% | 12.54% | -6.67% | -12.41% | Upgrade |
Free Cash Flow | 3,639 | 5,093 | 4,406 | 3,471 | 591.85 | 2,283 | Upgrade |
Free Cash Flow Per Share | 11.34 | 15.70 | 13.29 | 10.18 | 1.65 | 5.98 | Upgrade |
Dividend Per Share | 1.500 | 1.500 | 1.500 | 1.200 | 1.200 | 1.200 | Upgrade |
Dividend Growth | - | - | 25.00% | - | - | 9.09% | Upgrade |
Gross Margin | 40.11% | 39.98% | 38.88% | 35.41% | 36.91% | 37.39% | Upgrade |
Operating Margin | 14.30% | 14.27% | 13.95% | 11.95% | 11.57% | 11.97% | Upgrade |
Profit Margin | 3.68% | 3.63% | 3.65% | 2.45% | 2.77% | 3.45% | Upgrade |
Free Cash Flow Margin | 9.41% | 13.61% | 12.17% | 10.97% | 2.26% | 9.50% | Upgrade |
EBITDA | 6,074 | 5,937 | 5,696 | 4,420 | 3,582 | 3,480 | Upgrade |
EBITDA Margin | 15.71% | 15.86% | 15.73% | 13.97% | 13.69% | 14.48% | Upgrade |
D&A For EBITDA | 546.75 | 598.63 | 644.99 | 639.74 | 555.64 | 601.28 | Upgrade |
EBIT | 5,527 | 5,339 | 5,051 | 3,780 | 3,026 | 2,878 | Upgrade |
EBIT Margin | 14.30% | 14.27% | 13.95% | 11.95% | 11.57% | 11.97% | Upgrade |
Effective Tax Rate | 31.91% | 31.47% | 34.35% | 35.83% | 33.09% | 29.13% | Upgrade |
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.